Business leaders from Bill Ackman to Mark Cuban react to Trump's tariff pause
President Donald Trump on Wednesday announced a 90-day pause in his tariff plan against some countries.
Stocks, which had fallen following news of his aggressive strategy, surged in response to the pause.
Business leaders across the spectrum, from Bill Ackman to Mark Cuban, reacted disparately.
President Donald Trump on Wednesday announced via a social media post a planned 90-day pause in his aggressive tariff plan against some countries, sending ripples through the business community.
The market, which had plummeted following news of the president's trade strategy, surged in response to the planned pause, while industry leaders from across the political spectrum gave their initial reactions.
Billionaire hedge fund manager Bill Ackman, in a post on X, wrote, "This was brilliantly executed by @realDonaldTrump. Textbook, Art of the Deal."
Ackman had previously advocated for a pause in the tariffs' implementation "to enable negotiations to be completed without a major global economic disruption that will harm the most vulnerable companies and citizens of our country."
"The benefit of @realDonaldTrump 's approach is that we now understand who are our preferred trading partners, and who the problems are," Ackman said in a separate post following the announcement of the pause. "China has shown themselves to be a bad actor. Our counterparties also have a taste of what life is like if they don't take down their trade barriers. This is the perfect setup for trade negotiations over the next 90 days."
Ackman continued: "Advice for China: Pick up the phone and call the President. He is a tough but fair negotiator. The longer China holds out and retaliates, the worse the outcome for China."
Chris Fralic, a partner at the venture capital firm First Round Capital, posted on X a screenshot of the tickers of several surging stocks, writing it's, "Good to be liberated from Liberation Day."
"If your portfolio drops by X% and then rises by X%, you'll still be below your starting point," Fralic wrote in a separate post. "The bigger the drop, the more pronounced this effect becomes. A 20% drop followed by a 20% rise leaves you at 96% of your original value."
In response to a post by Shibetoshi Nakamoto, the pseudonym for Dogecoin co-creator Billy Markus, which read, "The next 4 years are gonna be an insane roller coaster, aren't they?" Tesla CEO Elon Musk replied simply with a "100" emoji.
Over on Bluesky, the X alternative social media site, Cost Plus Drugs cofounder and "Shark Tank" star Mark Cuban re-posted a statement from economist Paulo dos Santos, which described Trump's tariffs as "the Ivermectin of economic strategy," referencing the anti-parasitic drug used by some to treat COVID-19 infections, despite reservations from the medical community.
In a separate post made just before Trump announced the tariff pause, Cuban wrote: "What some people aren't factoring into their analysis is the reality that companies were buying tons of inventory to beat the tariffs. That's cash taken from being able to invest or hire. In fact the probably cut costs and jobs as a result."
Read the original article on Business Insider
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
15 minutes ago
- Business Upturn
Pharma stocks in focus as Trump announces tariffs on sector ‘soon'
Indian pharmaceutical stocks are in focus today after U.S. President Donald Trump announced that pharma tariffs are coming very soon. According to industry data, companies with the highest U.S. revenue exposure include Alembic Pharma (50%+), Aurobindo Pharma (45%+), and Dr. Reddy's and Zydus (both 40%). These firms are likely to be the most impacted if tariffs are introduced or raised on pharmaceutical imports from India. Here's a quick look at U.S. revenue exposure for key Indian pharma companies: Company % Revenue from U.S. Alembic 50%+ Aurobindo 45%+ Dr. Reddy's 40% Zydus 40% Lupin 34–38% Sun Pharma 30–35% Glenmark 30% Cipla 25–30% Torrent ~15–20% Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at


Washington Post
16 minutes ago
- Washington Post
'Purgatory:' Fed officials left in limbo as tariffs complicate this week's rate decision
WASHINGTON — The U.S. economy is mostly in good shape but that isn't saving Federal Reserve chair Jerome Powell from a spell of angst. As the Fed considers its next moves during a two-day meeting this week, most economic data looks solid: Inflation has been steadily fading , while the unemployment rate is still a historically low 4.2% . Yet President Donald Trump's widespread tariffs may push inflation higher in the coming months, while also possibly slowing growth .
Yahoo
18 minutes ago
- Yahoo
US stock futures lower amid Israel-Iran conflict
U.S. stock futures are lower after President Donald Trump abruptly left the Group of Seven summit in Canada. Trump had earlier urged everyone to immediately evacuate Tehran and reiterated that Iran should have signed a nuclear deal with the United States. Separately, a U.S. official said Trump would not sign a draft statement calling for de-escalation of the Israel-Iran conflict. Meanwhile, Israel is determined to continue its assault on Iran despite reports saying Iran wants to reopen nuclear talks. 'We're going to go about our operation to remove these two threats,' Israeli Strategic Affairs Minister Ron Dermer, referring to Iran's missile and nuclear programs, in a Bloomberg TV interview. 'Whether Iran will decide to meet with the United States and agree to terms that they should have taken a month ago, or two weeks ago, or two months ago, you know, that's up to Iran to decide.' At 6:15 a.m. ET, futures based on the blue-chip Dow fell-0.58%, while broad S&P 500 futures dropped -0.54% and tech-laden Nasdaq slipped -0.56%. Oil prices rose. May's retail sales data are due before the market opens. Economists surveyed by FactSet forecast a decline of 0.7% in total sales in May from April after a gain of just 0.1% in the prior month. However, the main event this week will be the Federal Reserve's rate policy decision due midweek. Almost everyone expects central bank policymakers to hold rates at their current target range of 4.25% to 4.50%, according to the CME FedWatch tool. Along with the Fed's policy announcement, central bankers will release their forecasts for economic growth, unemployment and inflation. Most economists expect the Fed's projections to show higher inflation in the second part of the year, a fairly low unemployment rate and slower economic growth. JPMorgan Chase, the country's biggest bank, has applied for a trademark related to digital currency with the United States Patent and Trademark Office (USPTO), leading to speculation the application for 'JPMD' means the bank is preparing to launch its own stablecoin. Stablecoins are digital assets designed to maintain a value in line with the U.S. dollar. TJPMorgan Chase filed the application on June 15, according to the USPTO's website. The application listed 'JPMD' as a good or service that would provide 'trading, exchange, transfer and payment services for digital assets,' among other categories related to cryptocurrencies and blockchain technology. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday. This article originally appeared on USA TODAY: US stock futures lower amid Israel-Iran conflict Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data